Coultreon Biopharma Raises $125 Million in Series A Financing to Advance Immunology Pipeline [Yahoo! Finance]
Galapagos NV - American Depositary Shares (GLPG)
Last galapagos nv - american depositary shares earnings: 10/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
glpg.com/company-overview
Company Research
Source: Yahoo! Finance
Proceeds to advance lead immunology program COL-5671, a potential first-in-class, oral once-daily therapy, across a range of auto-immune indications Leuven, Belgium. April 28, 2026 Coultreon Biopharma (formerly Onco3R Therapeutics), a biotechnology company developing best-in-class therapies in immunology, today announced the closing of an oversubscribed $125 million Series A financing round. Sofinnova Investments led the financing round, with Forbion and Novo Holdings as co-leads, joined by Galapagos, Regeneron Ventures, Balyasny Asset Management, Luma Group, Samsara BioCapital, Longwood Fund and Finchley Healthcare Ventures. Autoimmune diseases remain a significant area of unmet medical need, with many patients cycling through therapies that fail to deliver durable control of inflammation or disease progression. Coultreon's approach is rooted in more than 15 years of research into salt-inducible kinases (SIKs), a family of proteins that regulate key inflammatory pathways. The co
Show less
Read more
Impact Snapshot
Event Time:
GLPG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GLPG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GLPG alerts
High impacting Galapagos NV - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GLPG
News
- Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026GlobeNewswire
- RBC Cuts Galapagos NV (GLPG) Price Target to $28, Maintains Sector Perform Ahead of Q1 [Yahoo! Finance]Yahoo! Finance
- Galapagos Partners With Gilead on Gamgertamig, Unlocks $500M Cash and Eyes 2027 Registrational Trials [Yahoo! Finance]Yahoo! Finance
- Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases [Yahoo! Finance]Yahoo! Finance
- Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune DiseasesGlobeNewswire
GLPG
Earnings
- 2/23/26 - Beat
GLPG
Sec Filings
- 4/29/26 - Form 6-K
- 3/31/26 - Form 6-K
- 3/30/26 - Form 6-K
- GLPG's page on the SEC website